Neurology
Studies from the United States and Germany describe new findings in neurology research
Published in Gene Therapy Weekly, September 28th, 2006
Study 1: According to a study from the United States, genetically augmenting amyloid-beta (Abeta) 42 levels in skeletal muscle exacerbates inclusion body myositis (IBM)-like pathology and motor deficits in transgenic mice.
"The pathogenic basis of IBM, the leading muscle degenerative disease afflicting the elderly, is unknown, although the histopathological features are remarkably similar to those observed in Alzheimer disease. One leading hypothesis is that the buildup of Abeta peptide within selective skeletal muscle fibers contributes to the degenerative phenotype,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-09-28)
More Articles from Gene Therapy Weekly
- Endocrinology
Ghrelin amplifies dopamine signaling by cross talk - Endocrinology
Regulatory elements coordinate expression of a nicotinic receptor gene cluster - Genetics & Genomics
Retinal dystrophy point mutations decrease isomerohydrolase stability - RNA Research
Endothelial cell mRNA antisense oligodeoxynucleotides designed and screened - RNA Research
RNA interference machinery influences chromatin insulator nuclear organization - Atherosclerosis
Complement component induces macrophage plasminogen activator inhibitor - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
